Department: DEPARTMENT OF HEALTH AND HUMAN SERVICES

Advanced Search

Years: 2000200120022003200420052006200720082009

Pages: «<5758596061

[FR Doc E9-266] 1451. National Cancer Institute; Notice of Closed Meetings

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications/contract

Published: 2009-01-12 DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health

 

[FR Doc E9-264] 1452. National Center for Complementary & Alternative Medicine; Notice of Closed

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions

Published: 2009-01-12 DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health

 

[FR Doc E9-259] 1453. National Human Genome Research Institute; Notice of Meetings

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of meetings of the National Advisory Council for Human Genome Research.

The meetings will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need

Published: 2009-01-12 DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health

 

[FR Doc E9-270] 1454. National Institute of Allergy and Infectious Diseases; Notice of Closed

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the

Published: 2009-01-12 DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health

 

[FR Doc E9-272] 1455. National Institute of Allergy and Infectious Diseases; Notice of Meetings

Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of meetings of the AIDS Research Advisory Committee, NIAID.

The meetings will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign

Published: 2009-01-12 DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health

 

[FR Doc E9-277] 1456. National Institute of Dental & Craniofacial Research; Notice of Meetings

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of meetings of the National Advisory Dental and Craniofacial Research Council.

The meetings will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and

Published: 2009-01-12 DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health

 

[FR Doc E9-148] 1457. Medicare Program; Medicare Advantage and Prescription Drug Benefit Programs:

This rule contains final regulations governing the Medicare Advantage (MA) program (Part C) and prescription drug benefit program (Part D), and interim final regulations governing certain aspects of the Retiree Drug Subsidy (RDS) Program, and reflecting new statutory definitions relating to Special Needs Plans under Part C. The final regulations

Published: 2009-01-12 DEPARTMENT OF HEALTH AND HUMAN SERVICES : Veterans Affairs Department

 

[FR Doc E9-246] 1458. National Institute of Mental Health; Notice of Closed Meetings

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the

Published: 2009-01-12 DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health

 

[FR Doc E9-151] 1459. Medicare Program; Prescription Drug Benefit Program: Payments to Sponsors of

This proposed rule would make regulatory revisions based on a change in our interpretation of section 1860D22(b) of the Social Security Act. We would interpret this provision as providing us with the authority to ``waive or modify'' statutory requirements pertaining to the Retiree Drug Subsidy (RDS) program in order to facilitate the offering of a

Published: 2009-01-12 DEPARTMENT OF HEALTH AND HUMAN SERVICES : Veterans Affairs Department

 

[FR Doc E9-286] 1460. National Institute of Neurological Disorders and Stroke; Notice of Meeting

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the National Advisory Neurological Disorders and Stroke Council.

The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and

Published: 2009-01-12 DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health

 

[FR Doc E9-282] 1461. National Institute on Deafness and Other Communication Disorders; Notice of

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions

Published: 2009-01-12 DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health

 

[FR Doc E9-265] 1462. Oral Dosage Form New Animal Drugs; Phenylbutazone Tablets and Boluses

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by First Priority, Inc. The supplemental application provides for revising the description of a 1gram oral dosage form of phenylbutazone from tablet to bolus.

Published: 2009-01-12 DEPARTMENT OF HEALTH AND HUMAN SERVICES : Food and Drug Administration

 

[FR Doc E9-367] 1463. Meeting To Discuss Women's Health

The Food and Drug Administration (FDA), Office of Women's Health is announcing the following meeting: ``Women's Health Dialogue.'' The meeting is intended for directors of national organizations interested in discussing women's health research and educational out reach.

Date and Time: The meeting will be held on February 9, 2009, from 8:30

Published: 2009-01-12 DEPARTMENT OF HEALTH AND HUMAN SERVICES : Food and Drug Administration

 

[FR Doc E9-263] 1464. Clinical Center; Notice of Closed Meeting

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the Board of Scientific Counselors of the NIH Clinical Center.

The meeting will be closed to the public as indicated below in accordance with the provisions set forth in section 552b(c)(6), Title 5

Published: 2009-01-12 DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health

 

[FR Doc E9-292] 1465. Federal Financial Participation in State Assistance Expenditures; Federal

This document corrects a technical error that appeared in the notice published in the November 26, 2008 Federal Register entitled ``Federal Financial Participation in State Assistance Expenditures; Federal Matching Shares for Medicaid, the State Children's Health Insurance Program, and Aid to Needy Aged, Blind, or Disabled Persons for October 1,

Published: 2009-01-12 DEPARTMENT OF HEALTH AND HUMAN SERVICES : Health and Human Services Department

 

[FR Doc E9-258] 1466. Eunice Kennedy Shriver National Institute of Child Health & Human

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the National Advisory Child Health and Human Development Council.

The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and

Published: 2009-01-12 DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health

 

[FR Doc E9-65] 1467. Agency Information Collection Activities: Proposed Collection; Comment

Published: 2009-01-09 DEPARTMENT OF HEALTH AND HUMAN SERVICES : Centers for Medicare & Medicaid Services

 

[FR Doc E9-175] 1468. Agency Information Collection Activities; Submission for Office of Management

The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.

Published: 2009-01-09 DEPARTMENT OF HEALTH AND HUMAN SERVICES : Food and Drug Administration

 

[FR Doc E9-213] 1469. Agency Information Collection Activities; Proposed Collection; Comment

The Food and Drug Administration (FDA) is announcing an opportunity for public comment on the proposed collection of certain information by the agency. Under the Paperwork Reduction Act of 1995 (the PRA), Federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each

Published: 2009-01-09 DEPARTMENT OF HEALTH AND HUMAN SERVICES : Food and Drug Administration

 

[FR Doc E9-155] 1470. International Conference on Harmonisation; Guidance on Q4B Evaluation and

The Food and Drug Administration (FDA) is announcing the availability of a guidance entitled ``Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions; Annex 2: Test for Extractable Volume of Parenteral Preparations General Chapter.'' The guidance was prepared under the auspices of the International Conference on

Published: 2009-01-09 DEPARTMENT OF HEALTH AND HUMAN SERVICES : Food and Drug Administration

 

[FR Doc E9-176] 1471. Current List of Laboratories Which Meet Minimum Standards To Engage in Urine

The Department of Health and Human Services (HHS) notifies Federal agencies of the laboratories currently certified to meet the standards of Subpart C of the Mandatory Guidelines for Federal Workplace Drug Testing Programs (Mandatory Guidelines). The Mandatory Guidelines were first published in the Federal Register on April 11, 1988 (53 FR 11970),

Published: 2009-01-09 DEPARTMENT OF HEALTH AND HUMAN SERVICES : Substance Abuse and Mental Health Services Administration

 

[FR Doc E9-214] 1472. International Conference on Harmonisation; Guidance on Q4B Evaluation and

The Food and Drug Administration (FDA) is announcing the availability of a guidance entitled ``Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions; Annex 3: Test for Particulate Contamination: Subvisible Particles General Chapter.'' The guidance was prepared under the auspices of the International Conference on

Published: 2009-01-09 DEPARTMENT OF HEALTH AND HUMAN SERVICES : Food and Drug Administration

 

[FR Doc E9-189] 1473. Announcement of Final Priority Data Needs for Two Priority Hazardous

This notice announces the final priority data needs for two priority hazardous substances (see Table 1) as part of the continuing development and implementation of the ATSDR SubstanceSpecific Applied Research Program (SSARP). The notice also serves as a continuous call for voluntary research proposals.

The exposure and toxicity priority data

Published: 2009-01-09 DEPARTMENT OF HEALTH AND HUMAN SERVICES : Agency for Toxic Substances and Disease Registry

 

[FR Doc E9-52] 1474. Agency Information Collection Activities: Submission for OMB Review; Comment

Published: 2009-01-09 DEPARTMENT OF HEALTH AND HUMAN SERVICES : Centers for Medicare & Medicaid Services

 

[FR Doc E9-108] 1475. Agency Information Collection Activities; Submission for Office of Management

The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.

Published: 2009-01-08 DEPARTMENT OF HEALTH AND HUMAN SERVICES : Food and Drug Administration

 

Years: 2000200120022003200420052006200720082009

Pages: «<5758596061